Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000543802 | SCV000641618 | likely benign | Tuberous sclerosis 1 | 2024-12-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001018475 | SCV001179720 | likely benign | Hereditary cancer-predisposing syndrome | 2018-12-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000543802 | SCV002040346 | benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001018475 | SCV002531417 | likely benign | Hereditary cancer-predisposing syndrome | 2021-12-26 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002497130 | SCV002807557 | likely benign | Lymphangiomyomatosis; Tuberous sclerosis 1; Isolated focal cortical dysplasia type II | 2021-09-03 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000543802 | SCV004016087 | likely benign | Tuberous sclerosis 1 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003999217 | SCV004840448 | likely benign | Tuberous sclerosis syndrome | 2023-10-27 | criteria provided, single submitter | clinical testing |